Data as of Q4 2025 (Dec 31, 2025)

Bruce & Co., Inc.

โ€ขCIK: 1358331โ€ขFiling: Q4 2025

**Bruce & Co., Inc.** manages $323M across a portfolio of 39 positions, exhibiting a concentrated, value-oriented approach. Top holdings reveal significant allocations to healthcare and utilities, notably ABBV ($28.0M) and BEN ($26.4M). The fund maintains substantial exposure to defensive sectors, with combined positions in ABBV, BEN, ALS, and NEE exceeding $100M. This structure suggests a focus on established, resilient market leaders.

Total AUM
$322.5M
QoQ Performance
-0.1%
Positions
39
Top 10 Concentration
64.1%
Latest Filing
Q4 2025

Top Holdings Allocation

ABBV
AER
ALS
Next
UHAL/B
Merc
DUK
ABBV8.7%
AER8.2%
ALS8.1%
Nextera7.7%
UHAL/B6.6%
Merck6.3%
DUK5.7%
XEL4.5%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

KOD
Kodiak Sciences
-40.9%
1.4% of portfolio
ABT
Abbott
-14.9%
4.4% of portfolio
ABBV
Abbvie
-3.9%
8.7% of portfolio
DAR
Darling Ingredients
-19.1%
1.2% of portfolio
BG
Bunge
-12.5%
1.9% of portfolio

Sector Breakdown

Other71.2%
Healthcare15.9%
Utilities5.7%
Communication4.0%
Technology3.3%

Changes from Q3 2025

โ†“8 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023